You are here: Home » PTI Stories » National » News
Business Standard

Lupin gets 3 observations from USFDA for Aurangabad plant

Press Trust of India  |  New Delhi 

Wednesday said it has received three observations from the US health regulator for its Aurangabad-based

The (USFDA) carried out the inspection at the plant from May 6 to May 15, said in a statement.

"The inspection at the facility closed with three observations. The company is confident of addressing them satisfactorily," it added.

Shares of Wednesday ended 3.22 per cent lower at Rs 783.10 apiece on the BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, May 15 2019. 17:31 IST